Atlas Trials

Folfiri as Third Line of Treatment

Clinical trial NCT03486379 · COMPLETED

Trial details

NCT number
NCT03486379
Sponsor
IRCCS Cancer Referral Center of Basilicata
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric CancerRamucirumabThird Line
Start date
2016-03-01
Primary completion
2017-09-30
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.